LD-2 disclosure · 2nd Quarter - Report
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS
via AEGIS LLC
Client
- Description
- Biopharmaceutical company.
- Location
- New Jersey · United States of America
Registrant
- Firm
- AEGIS LLC
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
ADHD treatment. Implementation of the Infrastructure Investment and Jobs Act (or bipartisan infrastructure law). Traffic safety (distracted and impaired driving). Issues related to FDA approval. Patient access to non-opioid pain medicines. NO PAIN Act implementation. H.R.1227 / S.475: Alternatives to PAIN Act. Most-Favored Nation (MFN) International reference pricing. Make America Healthy Again (MAHA) Commission.
Lobbyistsms ANNE ELIZABETH ESPOSITO
Covered position (ms ANNE ELIZABETH ESPOSITO): Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Bilirakis)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Natl Highway Traffic Safety Administration (NHTSA)